Sign in

You're signed outSign in or to get full access.

David McCambridge

Director at NORTHRIM BANCORP
Board

About David J. McCambridge

Independent director of Northrim BanCorp, Inc. since 2011; age 69. Former KPMG audit partner (1978–2010) with deep accounting and financial services expertise; served as President/Director of the Alaska Kidney Foundation (1999–2020). The Board classifies him as independent and identifies him as an Audit Committee financial expert; he has chaired the Audit Committee since 2017 .

Past Roles

OrganizationRoleTenureCommittees/Impact
KPMG LLPAudit Partner1978–2010Public company audit experience; accounting expertise
Alaska Kidney FoundationPresident and Director1999–2020Nonprofit leadership
The Tanaka FoundationTreasurer and Director1985–2015Financial oversight
Great Alaska Council, Boy Scouts of AmericaDirector1993–2012Community leadership

External Roles

OrganizationRoleStatus/YearsNotes
Public company directorships (past 5 years)None disclosedProxy lists none for McCambridge in the past five years

Board Governance

  • Independence and tenure: Independent director; on the Board since 2011 .
  • Committee assignments: Audit Committee Chair since 2017; members in 2024 were McCambridge (Chair), Linda C. Thomas, and John C. Swalling; Audit Committee met five times in 2024 .
  • Financial expert: Board determined McCambridge qualifies as an Audit Committee financial expert .
  • Attendance: In 2024, all directors attended at least 75% of Board and committee meetings to which they were assigned; the Company Board met six times in 2024, and the Bank Board met six times .
  • Lead independent structure: Lead Independent Director is John C. Swalling, who presides over executive sessions of non-management directors .
Governance Metric2024 Data
Board meetings (Company)6
Board meetings (Bank)6
Audit Committee meetings5
Attendance threshold achieved (≥75%)Yes (all directors)
Independence statusIndependent
Audit Committee ChairYes (since 2017)
Audit financial expertYes

Fixed Compensation (Director)

Program structure for non-officer directors (2024):

  • Annual cash retainer (non-chair): $40,000 .
  • Chair retainers: Lead Director & Governance Chair $55,000; Audit Chair $46,000; Compensation Chair $45,000 (paid as the annual cash retainer for those roles) .
  • Additional cash for ownership alignment: $30,000 cash provided to each non-officer director to purchase NRIM stock on the open market after the 2024 annual meeting .
  • Meeting fees: $850 for each special meeting/strategic planning/training; $1,000 per Audit Committee meeting; $850 per Governance/Nominating or Compensation Committee meeting .
2024 Director Cash Compensation (Actuals)Amount
Total fees earned or paid in cash – McCambridge$83,550

Performance Compensation

  • No performance-based director equity or cash awards disclosed. Non-officer directors received a $30,000 cash amount designated for open-market stock purchases rather than RSUs/PSUs or options .
  • The Company’s 2025 proxy does not disclose performance metrics for director compensation; performance-share metrics disclosed in the proxy relate to executive awards, not director pay .
Performance-Linked Components for DirectorsStatus
RSUs/PSUs/options tied to performanceNot disclosed for directors

Other Directorships & Interlocks

  • Current public company boards: None disclosed for McCambridge in the past five years .
  • Compensation Committee interlocks: Company disclosed no interlocks/insider participation conflicts for the Compensation Committee in 2024 .

Expertise & Qualifications

  • Board skills matrix flags McCambridge for: financial services expertise, other board experience, other public company experience, accounting, and business management; also noted for community involvement .
  • Audit Committee financial expert designation by the Board .
  • Background as a long-tenured audit partner (KPMG) complements Audit Committee chair role .

Equity Ownership

Ownership ElementDetail
Beneficial ownership (3/31/2025)10,112 shares; less than 1% of outstanding shares
Directors & NEOs as a group219,630 shares (3.9% of outstanding)
Ownership guidelinesRecommendation: non-officer directors should purchase ≥3x their annual stock retainer and hold unencumbered; to be met within 5 years
Compliance with guidelinesAll non-officer directors subject to the guideline, other than Ms. Thomas, were in compliance as of 3/28/2025 (implies McCambridge in compliance)
Hedging/pledgingHedging prohibited; pledging strongly discouraged under Insider Trading Policy

Insider Trades

Recent open-market purchase reported in 2024:

DateTypeSharesApprox. ConsiderationPost-Trade Direct Holdings
2024-05-24Purchase (open market)2,200~$29,66210,112 shares
Sources: SEC Form 4 filing for 2024-05-24 and news coverage; company proxy ownership table reflects 10,112 shares as of 3/31/2025 .

Related Party / Conflicts

  • Regulation O insider lending policy in place; any insider loans approved on non-preferential terms and did not involve more than normal risk or other unfavorable features in 2024 (applies to directors and executives generally) .
  • Governance & Nominating Committee reviews/approves related-party transactions per charter .
  • Anti-hedging policy in effect; pledging discouraged .

Governance Environment Signals (Board-level)

  • Clawback policy adopted in 2023 covering incentive-based compensation upon a qualifying restatement .
  • 2024 Say-on-Pay approval ~94% (supportive shareholder sentiment) .
  • Board refreshment ongoing; McCambridge is among longer-tenured directors; Board added multiple new directors since 2014 and conducts annual/biannual evaluations with independent facilitation .
  • Cybersecurity oversight and ESG oversight delineated across Board and committees (Audit, Compensation, Governance & Nominating) .

Governance Assessment

  • Strengths

    • Independent Audit Chair with audit partner background; designated Audit Committee financial expert (enhances financial reporting oversight) .
    • Clear ownership alignment mechanisms for directors (mandatory cash to buy stock; ownership guideline; anti-hedging) .
    • Recent insider open-market purchase (positive alignment signal) .
    • No Compensation Committee interlocks; related-party transactions overseen and reported as arms-length .
  • Watch items

    • Long tenure (since 2011) amid ongoing refreshment; Board highlights continuing refreshment and evaluations to maintain effectiveness .
    • Pledging is discouraged (not prohibited); no pledging by McCambridge disclosed, but policy relies on discouragement rather than a strict ban .

Overall, McCambridge’s profile (independent Audit Chair, financial expert, meaningful ownership, recent open-market buy) supports board effectiveness and investor confidence, with no specific red flags disclosed in the latest proxy .